LumiraDx
IPOLondon, United Kingdom · Founded 2014
- Headquarters
- London
- Employees
- 501–1000
- Founded
- 2014
- Business Model
- B2B
- Website
- lumiradx.com
About
LumiraDx was a next-generation point-of-care diagnostics company founded in 2014 in the United Kingdom with a mission to transform community-based healthcare by bringing advanced diagnostics directly to the point of need. The company developed a proprietary microfluidic immunofluorescence platform capable of running 30+ rapid diagnostic tests—covering infectious diseases, cardiovascular conditions, diabetes, and coagulation disorders—with lab-comparable accuracy in under 15 minutes. LumiraDx deployed its platform globally with customers including CVS Pharmacy and the UK National Health Service, and was acquired by Roche Diagnostics for $295 million in 2024.
Summary
LumiraDx is a Biotech company based in London, United Kingdom, founded in 2014. Investors include CA Healthcare Acquisition Corp.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...